Similar articles

• The CATIE schizophrenia effectiveness trial.

  Delisi LE, Nasrallah HA. Delisi LE, et al. Schizophr Res. 2005 Dec 1;80(1):v-vi. doi: 10.1016/j.schres.2005.10.004. Schizophr Res. 2005. PMID: 16291292 No abstract available.
• Psychopharmacology news.

  Silva R. Silva R. J Child Adolesc Psychopharmacol. 2009 Feb;19(1):91. doi: 10.1089/cap.2009.1912. J Child Adolesc Psychopharmacol. 2009. PMID: 19232027 No abstract available.
• A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.

  Potkin SG, Gharabawi GM, Greenspan AJ, Mahmoud R, Kosik-Gonzalez C, Rupnow MF, Bossie CA, Davidson M, Burtea V, Zhu Y, Trivedi JK. Potkin SG, et al. Schizophr Res. 2006 Jul;85(1-3):254-65. doi: 10.1016/j.schres.2006.03.027. Epub 2006 Jun 21. Schizophr Res. 2006. PMID: 16797162 Clinical Trial.
• [Current pharmacotherapy of schizophrenia].

  Bitter I. Bitter I. Orv Hetil. 2004 Jan 18;145(3):105-9. Orv Hetil. 2004. PMID: 15027331 Review. Hungarian.
• [First episode psychoses: psychosocial, interpersonal and cognitive bases for a therapeutic approach].

  Di Michele V, Mazza M, Pollice R, Bolino F, Giosuè P, Roncone R, Casacchia M. Di Michele V, et al. Clin Ter. 2007 Jan-Feb;158(1):85-96. Clin Ter. 2007. PMID: 17405662 Review. Italian.